PEGylated "stealth" nanoparticles and liposomes

Zhiqiang Shen*, Alessandro Fisher, Wing K Liu, Ying Li

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Through nanomedicine, game-changing methods are emerging to deliver drug molecules directly to diseased tissue. The targeted delivery of drugs and imaging agents via drug carrier-based platforms is among the most promising of these methods. Such drug delivery systems can now be synthesized from a wide range of different materials, made in a number of different shapes, and coated with an array of different organic molecules, including ligands. In this chapter, we will focus on PEGylated liposomes and nanoparticles. By grafting polyethylene glycol (PEG) polymers on the surfaces of liposomes and other nanoparticles, protein absorption can be dramatically reduced, resulting in less macrophage cellular uptake and therefore prolonged blood circulation times in PEGylated over non-PEGylated nanomaterials. Through systematic experiments and computer simulations, the densely packed PEG polymers are found to play the most important role in this process, which is highly related to their conformation and free energy change. Such insights may provide guidance in the design of efficient drug carriers for clinical applications.

Original languageEnglish (US)
Title of host publicationEngineering of Biomaterials for Drug Delivery Systems
Subtitle of host publicationBeyond Polyethylene Glycol
PublisherElsevier Inc
Pages1-26
Number of pages26
ISBN (Electronic)9780081017517
ISBN (Print)9780081017500
DOIs
StatePublished - Jan 27 2018

Fingerprint

Drug Carriers
Liposomes
Nanoparticles
Polyethylene glycols
Polymers
Blood Circulation Time
Nanomedicine
Medical nanotechnology
Molecules
Nanostructures
Macrophages
Hemodynamics
Drug Delivery Systems
Nanostructured materials
Pharmaceutical Preparations
Computer Simulation
Free energy
Conformations
Ligands
Tissue

Keywords

  • Cellular uptake
  • Drug delivery
  • Nanomedicine
  • PEGylation
  • Protein corona

ASJC Scopus subject areas

  • Engineering(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Shen, Z., Fisher, A., Liu, W. K., & Li, Y. (2018). PEGylated "stealth" nanoparticles and liposomes. In Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol (pp. 1-26). Elsevier Inc. https://doi.org/10.1016/B978-0-08-101750-0.00001-5
Shen, Zhiqiang ; Fisher, Alessandro ; Liu, Wing K ; Li, Ying. / PEGylated "stealth" nanoparticles and liposomes. Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol. Elsevier Inc, 2018. pp. 1-26
@inbook{599d0283bcf0439cb099824a8bb54dfd,
title = "PEGylated {"}stealth{"} nanoparticles and liposomes",
abstract = "Through nanomedicine, game-changing methods are emerging to deliver drug molecules directly to diseased tissue. The targeted delivery of drugs and imaging agents via drug carrier-based platforms is among the most promising of these methods. Such drug delivery systems can now be synthesized from a wide range of different materials, made in a number of different shapes, and coated with an array of different organic molecules, including ligands. In this chapter, we will focus on PEGylated liposomes and nanoparticles. By grafting polyethylene glycol (PEG) polymers on the surfaces of liposomes and other nanoparticles, protein absorption can be dramatically reduced, resulting in less macrophage cellular uptake and therefore prolonged blood circulation times in PEGylated over non-PEGylated nanomaterials. Through systematic experiments and computer simulations, the densely packed PEG polymers are found to play the most important role in this process, which is highly related to their conformation and free energy change. Such insights may provide guidance in the design of efficient drug carriers for clinical applications.",
keywords = "Cellular uptake, Drug delivery, Nanomedicine, PEGylation, Protein corona",
author = "Zhiqiang Shen and Alessandro Fisher and Liu, {Wing K} and Ying Li",
year = "2018",
month = "1",
day = "27",
doi = "10.1016/B978-0-08-101750-0.00001-5",
language = "English (US)",
isbn = "9780081017500",
pages = "1--26",
booktitle = "Engineering of Biomaterials for Drug Delivery Systems",
publisher = "Elsevier Inc",

}

Shen, Z, Fisher, A, Liu, WK & Li, Y 2018, PEGylated "stealth" nanoparticles and liposomes. in Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol. Elsevier Inc, pp. 1-26. https://doi.org/10.1016/B978-0-08-101750-0.00001-5

PEGylated "stealth" nanoparticles and liposomes. / Shen, Zhiqiang; Fisher, Alessandro; Liu, Wing K; Li, Ying.

Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol. Elsevier Inc, 2018. p. 1-26.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - PEGylated "stealth" nanoparticles and liposomes

AU - Shen, Zhiqiang

AU - Fisher, Alessandro

AU - Liu, Wing K

AU - Li, Ying

PY - 2018/1/27

Y1 - 2018/1/27

N2 - Through nanomedicine, game-changing methods are emerging to deliver drug molecules directly to diseased tissue. The targeted delivery of drugs and imaging agents via drug carrier-based platforms is among the most promising of these methods. Such drug delivery systems can now be synthesized from a wide range of different materials, made in a number of different shapes, and coated with an array of different organic molecules, including ligands. In this chapter, we will focus on PEGylated liposomes and nanoparticles. By grafting polyethylene glycol (PEG) polymers on the surfaces of liposomes and other nanoparticles, protein absorption can be dramatically reduced, resulting in less macrophage cellular uptake and therefore prolonged blood circulation times in PEGylated over non-PEGylated nanomaterials. Through systematic experiments and computer simulations, the densely packed PEG polymers are found to play the most important role in this process, which is highly related to their conformation and free energy change. Such insights may provide guidance in the design of efficient drug carriers for clinical applications.

AB - Through nanomedicine, game-changing methods are emerging to deliver drug molecules directly to diseased tissue. The targeted delivery of drugs and imaging agents via drug carrier-based platforms is among the most promising of these methods. Such drug delivery systems can now be synthesized from a wide range of different materials, made in a number of different shapes, and coated with an array of different organic molecules, including ligands. In this chapter, we will focus on PEGylated liposomes and nanoparticles. By grafting polyethylene glycol (PEG) polymers on the surfaces of liposomes and other nanoparticles, protein absorption can be dramatically reduced, resulting in less macrophage cellular uptake and therefore prolonged blood circulation times in PEGylated over non-PEGylated nanomaterials. Through systematic experiments and computer simulations, the densely packed PEG polymers are found to play the most important role in this process, which is highly related to their conformation and free energy change. Such insights may provide guidance in the design of efficient drug carriers for clinical applications.

KW - Cellular uptake

KW - Drug delivery

KW - Nanomedicine

KW - PEGylation

KW - Protein corona

UR - http://www.scopus.com/inward/record.url?scp=85046872079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046872079&partnerID=8YFLogxK

U2 - 10.1016/B978-0-08-101750-0.00001-5

DO - 10.1016/B978-0-08-101750-0.00001-5

M3 - Chapter

SN - 9780081017500

SP - 1

EP - 26

BT - Engineering of Biomaterials for Drug Delivery Systems

PB - Elsevier Inc

ER -

Shen Z, Fisher A, Liu WK, Li Y. PEGylated "stealth" nanoparticles and liposomes. In Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol. Elsevier Inc. 2018. p. 1-26 https://doi.org/10.1016/B978-0-08-101750-0.00001-5